Precision Omics Intelligence
From molecular data to actionable intelligence
Nexyra is a Precision Omics Intelligence company.
We integrate multi-omics and clinical data with systems biology and AI to deliver validated biomarkers, predictive models, and decision-ready evidence for translational research and precision medicine.
Our work goes beyond descriptive analysis. We focus on validation, prediction and decision-making.
Why choose Nexyra Advanced Research
Clinical and R&D ready outputs
Customized solutions for your research and clinical practice projects
Mechanism-first intelligence
Biology-grounded multi-omics integration to surface causal signals and reduce false positives.
Explainable, traceable AI
Transparent models with clear feature attribution, audit trails and validation evidence.
Decision-ready deliverables
Ranked biomarkers, targets, and predictive/prognostic models packaged for real workflows.
Validated biomarker signatures
Diagnostic, predictive and prognostic biomarkers tested across independent cohorts.
Predictive & prognostic models
Molecular and clinical models to predict disease progression, patient stratification and treatment response.
Therapeutic intelligence
Identification of therapeutic targets and drug repurposing opportunities supported by multi-omics evidence.
Clinical grade outputs
Reports, molecular scores, and interactive dashboards ready for validation, trials and strategic decisions.
A RIGOROUS, BIOLOGY DRIVEN APPROACH
Multi-omics & clinical integration
Transcriptomics, metabolomics, exomes and clinical data harmonised under FAIR principles.
Systems biology & explainable AI
Models built on biological networks, pathways and regulatory mechanisms.
Translational & Therapeutic Intelligence
An evidence engine that turns biomarker signals into therapy-relevant decisions: which target, which patient, which intervention and with what level of confidence
Therapeutic Target Prioritization
Ranked target lists backed by multi-omics evidence, mechanistic coherence, cell/tissue context, and biological risk flags.
Drug Repurposing & Indication Expansion
Prioritized compound opportunities with mechanism-based rationale, omics/clinical support, and proposed responder subgroups.
Translational Research Programs
Hypothesis-driven study design and experimental planning: companion biomarkers, patient stratification, endpoints, and enrichment criteria.
Focused on teams that need reliable decisions
At Nexyra, we harness the power of advanced multi-omics integration to redefine how clinical questions are addressed. Our platform unifies omics signals with clinical ontologies and more.
BIOTECH COMPANIES
HOSPITALS
RESEARCH GROUPS
AND
PRECISION MEDICINE AND MOLECULAR DIAGNOSTICS PROGRAMS
This innovative approach transforms fragmented data into actionable knowledge, supporting clinicians, researchers, and industry in advancing precision and humane medicine
BUILT FOR RELIABILITY
Reproducibility first
Validation across independent cohorts is a core requirement.
Explainable by design
Every model and biomarker is biologically interpretable and scientifically defensible.
Regulatory aware
Data lineage, traceability, and documentation aligned with clinical validation and regulatory needs.
Fast decisions
Actionable results delivered on defined, decision-focused timelines.
From multi-omics data to decisions you can trust
This is Omics data AI-enabled precision medicine
This is the future of healthcare.
Scientific and Institutional collaborations
Developed in collaboration with leading academic, technological and innovation institutions.
